MTOR and chronic myelogenous leukemia, BCR-ABL1 positive: In BCR-ABL-expressing chronic myeloid leukemia (CML) precursors and ALL cells that are positive for the Philadelphia chromosome (Ph+), metformin, and AICAR suppressed the mTOR pathway and cell growth (58).